
ORBIMED ADVISORS LLC
Latest 13F filing data - Q3 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | RNA | 1.64M | $71.41M |
![]() | MLYS | 1.47M | $55.72M |
![]() | IRON | 1.42M | $93.50M |
![]() | AVTX | 1.35M | $17.15M |
![]() | FBRX | 1.20M | $17.95M |
![]() | GPCR | 1.14M | $31.90M |
![]() | CRNX | 1.10M | $45.77M |
![]() | RAPT | 1.09M | $28.02M |
![]() | KROS | 1.02M | $16.12M |
![]() | EXAS | 995K | $54.42M |
![]() | BCRX | 902K | $6.84M |
![]() | VSTM | 888K | $7.84M |
![]() | BIOA | 791K | $4.65M |
![]() | AMLX | 751K | $10.20M |
![]() | URGN | 689K | $13.75M |
![]() | TRAW | 606K | $1.12M |
![]() | MURA | 589K | $1.22M |
![]() | AXSM | 532K | $64.59M |
![]() | JBIO | 531K | $4.58M |
![]() | AKRO | 526K | $24.98M |

Avidity Biosciences, Inc.
RNA
Shares Held
1.64M
Value
$71.41M

Mineralys Therapeutics, Inc.
MLYS
Shares Held
1.47M
Value
$55.72M

Disc Medicine, Inc.
IRON
Shares Held
1.42M
Value
$93.50M

Avalo Therapeutics, Inc.
AVTX
Shares Held
1.35M
Value
$17.15M

Forte Biosciences, Inc.
FBRX
Shares Held
1.20M
Value
$17.95M

Structure Therapeutics Inc.
GPCR
Shares Held
1.14M
Value
$31.90M

Crinetics Pharmaceuticals, Inc.
CRNX
Shares Held
1.10M
Value
$45.77M

RAPT Therapeutics, Inc.
RAPT
Shares Held
1.09M
Value
$28.02M

Keros Therapeutics, Inc.
KROS
Shares Held
1.02M
Value
$16.12M

Exact Sciences Corporation
EXAS
Shares Held
995K
Value
$54.42M

BioCryst Pharmaceuticals, Inc.
BCRX
Shares Held
902K
Value
$6.84M

Verastem, Inc.
VSTM
Shares Held
888K
Value
$7.84M

BioAge Labs, Inc.
BIOA
Shares Held
791K
Value
$4.65M

Amylyx Pharmaceuticals, Inc.
AMLX
Shares Held
751K
Value
$10.20M

UroGen Pharma Ltd.
URGN
Shares Held
689K
Value
$13.75M

Traws Pharma, Inc.
TRAW
Shares Held
606K
Value
$1.12M

Mural Oncology plc
MURA
Shares Held
589K
Value
$1.22M

Axsome Therapeutics, Inc.
AXSM
Shares Held
532K
Value
$64.59M

Jade Biosciences, Inc.
JBIO
Shares Held
531K
Value
$4.58M

Akero Therapeutics, Inc.
AKRO
Shares Held
526K
Value
$24.98M
